NARS2 Gene Combined Oxidative Phosphorylation Deficiency Type 24 Genetic Test
Test Name: NARS2 Gene Combined Oxidative Phosphorylation Deficiency Type 24 Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Metabolic Disorders
Doctor: General Physician
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for NARS2 Gene Combined Oxidative Phosphorylation Deficiency Type 24 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Combined Oxidative Phosphorylation Deficiency Type 24.
Test Details
The NARS2 gene is associated with Combined Oxidative Phosphorylation Deficiency Type 24, a rare genetic disorder that affects the function of mitochondria in cells. Mitochondria are responsible for producing energy in the form of ATP through a process called oxidative phosphorylation.
A NGS (Next-Generation Sequencing) genetic test for NARS2 gene mutations can help diagnose this condition by analyzing the DNA sequence of the gene. This test can identify specific mutations or variants in the NARS2 gene that may be causing the mitochondrial dysfunction.
Combined Oxidative Phosphorylation Deficiency Type 24 can lead to a range of symptoms, including developmental delay, intellectual disability, muscle weakness, hearing loss, and other neurological problems.
Early diagnosis through genetic testing can help guide treatment and management strategies for affected individuals. It is important to consult with a healthcare professional or genetic counselor to discuss the specific details and implications of NARS2 gene testing for Combined Oxidative Phosphorylation Deficiency Type 24. They can provide more information about the test, its accuracy, potential risks, and available treatment options.
Test Name | NARS2 Gene Combined oxidative phosphorylation deficiency type 24 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for NARS2 Gene Combined oxidative phosphorylation deficiency type 24 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Combined oxidative phosphorylation deficiency type 24 |
Test Details |
The NARS2 gene is associated with Combined Oxidative Phosphorylation Deficiency Type 24, a rare genetic disorder that affects the function of mitochondria in cells. Mitochondria are responsible for producing energy in the form of ATP through a process called oxidative phosphorylation. A NGS (Next-Generation Sequencing) genetic test for NARS2 gene mutations can help diagnose this condition by analyzing the DNA sequence of the gene. This test can identify specific mutations or variants in the NARS2 gene that may be causing the mitochondrial dysfunction. Combined Oxidative Phosphorylation Deficiency Type 24 can lead to a range of symptoms, including developmental delay, intellectual disability, muscle weakness, hearing loss, and other neurological problems. Early diagnosis through genetic testing can help guide treatment and management strategies for affected individuals. It is important to consult with a healthcare professional or genetic counselor to discuss the specific details and implications of NARS2 gene testing for Combined Oxidative Phosphorylation Deficiency Type 24. They can provide more information about the test, its accuracy, potential risks, and available treatment options. |